RocketTickers

Zogenix Announces Positive Top-Line Results from its Third Pivot

Long
NASDAQ:ZGNX   None
ZGNX: Zogenix, Inc
2020-09-10 08:00:10
Zogenix Announces Positive Top-Line Results from its Third Pivotal Phase 3 Clinical Trial (Study 3) of FINTEPLA® in Dravet Syndrome
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.